New drug trial aims to break nicotine vaping addiction
Disease control
Not yet recruiting
This study is testing whether a medication called cytisinicline, combined with behavioral support, can help adults quit using nicotine e-cigarettes. About 800 daily vapers will be randomly assigned to receive either the real medication or a placebo pill for 12 weeks. The main goa…
Phase: PHASE3 • Sponsor: Achieve Life Sciences • Aim: Disease control
Last updated Mar 30, 2026 14:30 UTC